NIH-funded research NIH-funded research

National Crystallization Center: Access to Cutting-Edge 3D Structure Tools

Official title: National Crystallization Center: Enabling Access to State-of-the-Art Crystallization Capabilities

Funded at State University of New York at Buffalo · NIH-11422533 · Data updated 2026-11-12

A national center aims to provide researchers with world-class crystallization capabilities to determine 3D structures of biomolecules, helping advance drug design, biomaterials, and energy-related research.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionState University of New York at Buffalo
NIH-funded
Lab location1 site (Amherst, United States)
Project startJuly 1, 2021
Project endJuly 31, 2031
Funding year2026
Award (this year)$1,125,700
NIH project number2R24GM141256-07
Project IDNIH-11422533 on NIH RePORTER

Who could benefit from this research

Could help

Researchers and clinicians working on diseases or therapies that require precise biomolecular structures and structure-guided design.

Less likely to help

Direct patient benefit may be indirect or long-term; not all health advances will translate immediately to individual patients.

What this research studies

This project focuses on enabling researchers to obtain high-resolution 3D structures of biomolecules by improving crystallization approaches and integrating computational tools. It addresses bottlenecks in macromolecular X-ray crystallography and leverages AI-based predictions to complement experimental data. By expanding access to advanced crystallization resources, it supports discoveries across medicine, materials science, and energy technologies from a patient-centered perspective through better therapies and novel biomaterials.

Why it matters

Potential benefit: If successful, patients could benefit from faster development of targeted drugs and new biomaterials for health and energy applications.

How similar studies have gone: Previous crystallography efforts and AI-augmented structure prediction have improved model accuracy, but challenges remain for hard targets like membrane proteins.

Where this research is happening

  • State University of New York at Buffalo
    Amherst, United States
    Active

Researchers

  • Principal investigator: Bowman, Sarah Elizabeth Johnson — State University of New York at Buffalo
  • Study coordinator: Bowman, Sarah Elizabeth Johnson

Related research

Other NIH-funded projects on the same topics.

  • Improving population health by studying reproductive health and development.

    This study is looking at how different factors, like the environment and genetics, affect the health of pregnant women and people of reproductive age, with the goal of improving pregnancy outcomes and the health of children as they grow up.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-9795452

  • How noise and hearing loss affect the first step of hearing in the brain

    This NIH grant studies how noise and conductive hearing loss change the intimate connections between auditory nerves and brain cells, which could influence how we hear in noisy environments.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11620270

  • Programmable hydrogels to protect transplanted human OPCs in demyelinating disease

    Aims to improve survival and integration of transplanted human oligodendrocyte precursor cells by using specially designed hydrogels to reduce cell death during delivery in demyelinating diseases like multiple sclerosis.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11579956

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

  • New dual-acting treatments against tough Klebsiella pneumoniae infections

    A new funding opportunity aims to develop therapies that both fight and disarm the dangerous Klebsiella pneumoniae bacteria, especially strains that resist many drugs, to help patients with serious infections.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11563773

  • Muscle health and aging in postmenopausal women

    This NIH grant supports a study in older, postmenopausal women to understand how insulin and blood sugar relate to muscle loss over time and whether this differs by race/ethnicity.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11532334

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.